Oncternal Therapeutics, Inc.Oncternal Therapeutics, Inc.Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

ONCT fundamenta

Oncternal Therapeutics, Inc. earnings per share and revenue

ONCT earnings per share for the last quarter are -2.83 USD whereas the estimation was -2.88 USD which accounts for 1.65% surprise. Företagets omsättning för samma period uppgår till 569.00 k USD trots den uppskattade siffran 183.33 k USD. Estimated earnings per share for the next quarter are -2.65 USD, and revenue is expected to reach 225.00 k USD. Also watch annual changes over time to get a bigger picture of ONCT earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning